Merck to support Transgene and BioInvent led oncolytic virus clinical trial

cafead

Administrator
Staff member
  • cafead   Jun 28, 2022 at 06:02: PM
via MSD will supply Keytruda (pembrolizumab) in a phase 1/2a clinical trial for the treatment of patients with solid tumors, as part of an agreement with Transgene and BioInvent.

article source